Reinvestment and compounding describe the engine of intrinsic-value growth: a company retains some fraction of its earnings, redeploys it into the business, and earns a return on that new capital — and when those returns are themselves retained and redeployed, value grows geometrically rather than linearly. The framework's central insight is that growth is not free and not uniformly valuable. Earnings growth only creates value when capital is reinvested at returns above the cost of capital; growth funded by reinvestment at low returns can destroy value even as the income statement gets bigger. The core tension is therefore between the amount a firm can reinvest (its runway) and the quality of that reinvestment (the incremental return). Both must be present for the compounding flywheel to spin.

How it's calculated

Two equivalent formulations are standard, depending on whether you work from equity earnings or from total operating capital.

Equity / Sustainable Growth Rate (SGR), attributed to Robert C. Higgins:

g = Retention Ratio × ROE

where the retention (or "plowback") ratio = 1 − dividend payout ratio, and ROE is return on equity. This is the rate at which a firm can grow equity earnings without raising new equity or increasing leverage (Wall Street Prep; Higgins, Analysis for Financial Management). It expands via DuPont into net margin × asset turnover × leverage × retention.

Operating / firm level (Damodaran):

Expected growth in EBIT = Reinvestment Rate × Return on Invested Capital (ROIC)

where Reinvestment Rate = (net capex + change in working capital) ÷ after-tax operating income.

The forward-looking, value-relevant version uses incremental returns:

Intrinsic-value compounding rate ≈ Reinvestment Rate × ROIIC

ROIIC (return on incremental invested capital) = change in operating earnings ÷ the new capital invested to produce it. ROIIC matters more than trailing ROIC because compounding is driven by what the next dollar earns, not what past dollars earned (Saber Capital Management; einvestingforbeginners).

How to read it

The product is what counts, and it can be reached by different routes. A business earning 20% on incremental capital while reinvesting 50% of earnings compounds value at ~10% (0.20 × 0.50) — and the unused 50% can fund buybacks or dividends. A business reinvesting 100% of earnings at 10% also compounds at ~10%, but with no cash left over (Saber Capital Management). The first is the superior business: same growth, plus surplus capital. As a rough reading guide: ROIC/ROIIC well above ~10% (a common proxy for the cost of capital) signals value-creating reinvestment; returns at or below the cost of capital mean growth adds size but little or no value. A firm with high ROIC but a low reinvestment rate is a quality business with a short runway — it compounds slowly and should return cash rather than force low-return reinvestment.

How it's used in practice

• Compounder / quality investing. The dominant application. Investors seek firms that can reinvest a large share of earnings at high incremental returns for many years ("high ROIC + long runway"), letting time do the heavy lifting. This is the analytical core of the Buffett-Munger / quality-growth school.
• Buffett's $1 retained-earnings test (1984 letter). Sum retained earnings (Buffett favored a 3-to-5-year window to smooth market volatility); compare the change in market value over the same period. If each $1 retained created ≥$1 of market value, management is allocating capital well. It is a blunt, backward-looking sanity check on reinvestment quality, distinct from a single-period ROIC.
• DCF / intrinsic-value modeling. Reinvestment rate × return on capital is the standard way to internally derive a growth rate in a discounted-cash-flow model, forcing consistency between assumed growth and the capital (and returns) needed to fund it — a discipline against the common error of assuming high growth with low reinvestment.
• Capital-allocation screening. Comparing ROIIC across reinvestment options (organic growth, M&A, buybacks, dividends) is the framework managers and analysts use to judge where retained earnings should go.

Standing & evidence

The mechanics are arithmetic identities, not contested theory. The contested part is whether selecting for high-return reinvestment produces excess stock returns. The evidence is supportive but not absolute: Novy-Marx's 2013 "gross profitability" work (gross profits-to-assets) showed profitability had roughly the same cross-sectional return power as the value factor, and the broader "quality factor" literature has found quality composites historically outperform. Validea's summary of this literature cites a four-pillar quality composite (profitability, growth, safety, payout) outperforming by over 4% annually 1963–2013 — note this composite figure is distinct from, and broader than, the original gross-profitability premium. High-ROIC cohorts have shown measurable long-run outperformance over low-ROIC cohorts in several manager studies (e.g., Segall Bryant & Hamill), and ROIC is often described as the most persistent of the quality metrics. Caveats: much of this evidence comes from practitioner/manager research rather than peer review and is exposed to data-mining and survivorship concerns; quality strategies underperform in deep "junk rallies"; and high ROIC is frequently already priced in, so the valuation paid governs realized return. Damodaran's warnings apply directly: reinvestment inputs are volatile (use 3–5-year averages), and current returns far above the industry average should be faded toward the mean for competitive erosion.

Strengths & limitations

Strengths. Ties growth to its source, exposing "empty calorie" growth that consumes capital without creating value. It is the cleanest single lens for separating great businesses (high incremental returns, long runway) from merely large ones. It enforces internal consistency in valuation models.

Limitations / failure modes. (1) Trailing ROIC ≠ ROIIC. A firm can post a high reported ROIC on legacy assets yet earn dismal returns on new investment — the compounding story quietly breaks. Always check incremental returns. (2) Runway is finite. Mean reversion and competition compress returns; extrapolating high reinvestment-rate × high-return far into the future is the #1 overvaluation trap. (3) Accounting distortions. Intangible-heavy and R&D/lease-adjusted firms have ROIC understated or overstated depending on capitalization treatment; goodwill from acquisitions can mask poor incremental returns. (4) Manipulable inputs. Reinvestment rate and capital base are noisy and definition-sensitive. The single most common misuse: equating earnings growth with value creation — growing EPS while reinvesting at returns below the cost of capital is value destruction dressed as success.

System relevance

This node sits in Fundamental Analysis > Growth Analysis. It is the quality-of-growth counterpart to siblings covering revenue/earnings growth rates and total addressable market: those measure how fast a company is growing, this measures whether that growth is worth anything. It connects to ROIC/ROE definition nodes and to DCF/intrinsic-value nodes (where g is derived from reinvestment × return). It has no native swing-trading angle — it is a long-horizon, business-quality concept and should not be forced into a short-term setup frame.

Sources

• Damodaran, The Fundamental Determinants of Growth — pages.stern.nyu.edu/~adamodar (Expected growth = Reinvestment Rate × Return on Capital; quality/volatility caveats)
• Wall Street Prep, Sustainable Growth Rate (SGR) — g = Retention × ROE; Higgins attribution
• Saber Capital Management, Importance of ROIC Parts 3 & 4 (intrinsic value compounding = Reinvestment Rate × ROIC; 20%×50% vs 100%×10% examples; ROIIC priority)
• einvestingforbeginners — ROIIC definition; Buffett's $1 retained-earnings test (1984 Berkshire letter)
• Validea, The Quality Factor — summary of Novy-Marx quality-factor outperformance evidence
• Segall Bryant & Hamill, The Return Advantage of High ROIC Investing — high- vs low-ROIC cohort returns (manager research; treat as suggestive)